| Id |
Subject |
Object |
Predicate |
Lexical cue |
| p1_all0 |
1079-1114 |
Intervention |
denotes |
23 caveolin chaperone complex (CCC) |
| p1_all1 |
1593-1606 |
Outcome |
denotes |
NS1 secretion |
| p2_o11 |
1593-1606 |
Physical |
denotes |
NS1 secretion |
| p2_o11 |
1638-1692 |
Physical |
denotes |
recombinant luciferase 29 secretion and virion release |
| p1_all2 |
1638-1693 |
Outcome |
denotes |
recombinant luciferase 29 secretion and virion release. |
| p1_all3 |
1778-1790 |
Intervention |
denotes |
cyclosporine |
| p2_i0 |
1778-1790 |
Pharmacological |
denotes |
cyclosporine |
| p1_all4 |
1829-1842 |
Outcome |
denotes |
NS1 secretion |
| p2_o12 |
1829-1842 |
Physical |
denotes |
NS1 secretion |
| p1_all5 |
2089-2116 |
Outcome |
denotes |
CAV-1 and FKBP52 expression |
| p2_o14 |
2089-2116 |
Physical |
denotes |
CAV-1 and FKBP52 expression |
| p1_all6 |
2275-2288 |
Outcome |
denotes |
NS1 secretion |
| p2_o15 |
2275-2288 |
Physical |
denotes |
NS1 secretion |
| p2_i1 |
2352-2374 |
Pharmacological |
denotes |
co-localize with CAV-1 |
| p1_all7 |
3361-3447 |
Outcome |
denotes |
47 expression or the activity of chaperone caveolin complex in mosquito infected cells |
| p2_o29 |
3655-3707 |
Physical |
denotes |
expression of the caveolin-1 and co-chaperone FKBP52 |
| p2_p0 |
4300-4305 |
Sample-size |
denotes |
57 58 |
| p1_all8 |
4300-4323 |
Population |
denotes |
57 58 59 4 64 infection |
| p2_p1 |
4306-4327 |
Condition |
denotes |
59 4 64 infection and |
| p1_all9 |
4807-4839 |
Outcome |
denotes |
viral genome replication process |
| p1_all10 |
5622-5625 |
Intervention |
denotes |
NS1 |
| p2_i2 |
5622-5625 |
Pharmacological |
denotes |
NS1 |
| p1_all11 |
6735-6786 |
Intervention |
denotes |
bioRxiv preprint 5 87 a polygonal net-like complex. |
| p1_all12 |
7251-7283 |
Intervention |
denotes |
chaperone caveolin complex (CCC) |
| p1_all13 |
7433-7436 |
Intervention |
denotes |
CCC |
| p1_all14 |
7605-7624 |
Intervention |
denotes |
Cyclophilin A (CyA) |
| p2_i3 |
7605-7624 |
Pharmacological |
denotes |
Cyclophilin A (CyA) |
| p2_i4 |
7775-7789 |
Pharmacological |
denotes |
cyclosporine A |
| p1_all15 |
7775-7794 |
Intervention |
denotes |
cyclosporine A, CyA |
| p2_i5 |
7791-7794 |
Pharmacological |
denotes |
CyA |
| p1_all16 |
7873-7910 |
Intervention |
denotes |
52-kDa FK506-binding protein (FKBP52) |
| p1_all17 |
8156-8177 |
Intervention |
denotes |
Cyclophilin 40 (Cy40) |
| p2_i6 |
8156-8177 |
Pharmacological |
denotes |
Cyclophilin 40 (Cy40) |
| p1_all18 |
9588-9607 |
Outcome |
denotes |
cytotoxicity of GCA |
| p1_all19 |
9857-9869 |
Outcome |
denotes |
cytotoxicity |
| p2_o67 |
9857-9869 |
Physical |
denotes |
cytotoxicity |
| p2_i7 |
9948-9954 |
Pharmacological |
denotes |
Fli-06 |
| p1_all20 |
10061-10080 |
Outcome |
denotes |
Fli-06 cytotoxicity |
| p1_all21 |
10183-10199 |
Outcome |
denotes |
123 cytotoxicity |
| p2_o70 |
10187-10199 |
Physical |
denotes |
cytotoxicity |
| p1_all22 |
10615-10628 |
Outcome |
denotes |
NS1 secretion |
| p2_o73 |
10615-10628 |
Physical |
denotes |
NS1 secretion |
| p1_all23 |
10734-10748 |
Outcome |
denotes |
virion release |
| p1_all24 |
11377-11384 |
Intervention |
denotes |
Fli-133 |
| p2_i8 |
11377-11384 |
Pharmacological |
denotes |
Fli-133 |
| p1_all25 |
12077-12094 |
Intervention |
denotes |
140 GCA treatment |
| p1_all26 |
12138-12141 |
Intervention |
denotes |
GCA |
| p1_all27 |
12264-12287 |
Outcome |
denotes |
luciferase 142 activity |
| p2_o85 |
12264-12287 |
Physical |
denotes |
luciferase 142 activity |
| p1_all28 |
13224-13243 |
Intervention |
denotes |
Cyclosporin A (CsA) |
| p1_all29 |
13489-13538 |
Intervention |
denotes |
bioRxiv preprint 8 154 knocked down using siRNAs. |
| p2_o95 |
13555-13582 |
Physical |
denotes |
non-cytotoxic concentration |
| p1_all30 |
13555-13627 |
Outcome |
denotes |
non-cytotoxic concentration for CsA in mosquito 155 and vertebrate cells |
| p2_i9 |
13664-13684 |
Pharmacological |
denotes |
DENV4-infected C6/36 |
| p1_all31 |
13744-13757 |
Outcome |
denotes |
NS1 secretion |
| p1_all32 |
13857-13871 |
Outcome |
denotes |
virion release |
| p2_o99 |
14117-14170 |
Physical |
denotes |
participation of CyA in cholesterol and lipid traffic |
| p1_all33 |
14117-14195 |
Outcome |
denotes |
participation of CyA in cholesterol and lipid traffic, the lipid droplet count |
| p2_o99 |
14176-14195 |
Physical |
denotes |
lipid droplet count |
| p1_all34 |
14314-14317 |
Intervention |
denotes |
CsA |
| p2_i10 |
14314-14317 |
Pharmacological |
denotes |
CsA |
| p1_all35 |
14338-14371 |
Outcome |
denotes |
amount of lipid droplets per cell |
| p2_o100 |
14338-14371 |
Physical |
denotes |
amount of lipid droplets per cell |
| p2_o101 |
14439-14459 |
Physical |
denotes |
expression of FKBP52 |
| p1_all36 |
14607-14613 |
Intervention |
denotes |
FKPB52 |
| p2_i11 |
14607-14613 |
Pharmacological |
denotes |
FKPB52 |
| p1_all37 |
14640-14672 |
Outcome |
denotes |
cholesterol and lipid metabolism |
| p2_o103 |
14640-14672 |
Physical |
denotes |
cholesterol and lipid metabolism |
| p2_o103 |
14701-14736 |
Physical |
denotes |
lipid droplet 167 counting per cell |
| p1_all38 |
14773-14797 |
Outcome |
denotes |
number of lipid droplets |
| p1_all39 |
14868-14880 |
Intervention |
denotes |
siRNA FKBP52 |
| p1_all40 |
14909-14912 |
Outcome |
denotes |
NS1 |
| p2_o104 |
14909-14912 |
Physical |
denotes |
NS1 |
| p1_all41 |
14965-14978 |
Outcome |
denotes |
Viral release |
| p2_o105 |
14965-14978 |
Physical |
denotes |
Viral release |
| p1_all42 |
15043-15049 |
Intervention |
denotes |
FKBP52 |
| p2_i12 |
15043-15049 |
Pharmacological |
denotes |
FKBP52 |
| p1_all43 |
15241-15274 |
Intervention |
denotes |
HSP90 inhibitor geldanamycin (GA) |
| p1_all44 |
15361-15374 |
Outcome |
denotes |
NS1 secretion |
| p2_o108 |
15361-15374 |
Physical |
denotes |
NS1 secretion |
| p1_all45 |
15577-15590 |
Outcome |
denotes |
NS1 secretion |
| p2_o110 |
15577-15590 |
Physical |
denotes |
NS1 secretion |
